Literature DB >> 6318262

Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy.

J T Ungerleider, T A Andrysiak, L A Fairbanks, A S Tesler, R G Parker.   

Abstract

The authors tested the effectiveness of orally administered delta-9-tetrahydrocannabinol (THC) as compared to prochlorperazine for the alleviation of symptoms, such as vomiting and nausea, experienced by patients receiving radiotherapy. The test subjects rated the severity of their illness, as well as the extent of their subsequent moods, their level of concentration, their amount of physical activity, and their desire for social interaction. They chose the drug they preferred and recorded its side effects. The use of THC was slightly more beneficial than the use of prochlorperazine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6318262     DOI: 10.1148/radiology.150.2.6318262

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

Review 1.  Marijuana Use in Pregnancy and While Breastfeeding.

Authors:  Torri D Metz; Laura M Borgelt
Journal:  Obstet Gynecol       Date:  2018-11       Impact factor: 7.661

Review 2.  Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines.

Authors:  Petra Ch Feyer; Ernesto Maranzano; Alexander Molassiotis; Rebecca A Clark-Snow; Fausto Roila; David Warr; Ian Olver
Journal:  Support Care Cancer       Date:  2004-12-08       Impact factor: 3.603

Review 3.  A systematic review of methodologies, endpoints, and outcome measures in randomized trials of radiation therapy-induced nausea and vomiting.

Authors:  Kristopher Dennis; Rehana Jamani; Clare McGrath; Leila Makhani; Henry Lam; Patrick Bauer; Carlo De Angelis; Natalie Coburn; C Shun Wong; Edward Chow
Journal:  Support Care Cancer       Date:  2017-03-31       Impact factor: 3.603

Review 4.  Regulation of nausea and vomiting by cannabinoids.

Authors:  Linda A Parker; Erin M Rock; Cheryl L Limebeer
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

5.  Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.

Authors:  E M Rock; R L Kopstick; C L Limebeer; L A Parker
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

6.  Anticipatory nausea in animal models: a review of potential novel therapeutic treatments.

Authors:  Erin M Rock; Cheryl L Limebeer; Linda A Parker
Journal:  Exp Brain Res       Date:  2014-05-04       Impact factor: 1.972

7.  Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009.

Authors:  Petra Christine Feyer; Ernesto Maranzano; Alexander Molassiotis; Fausto Roila; Rebecca A Clark-Snow; Karin Jordan
Journal:  Support Care Cancer       Date:  2010-08-10       Impact factor: 3.603

8.  Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system.

Authors:  Keith A Sharkey; Nissar A Darmani; Linda A Parker
Journal:  Eur J Pharmacol       Date:  2013-11-01       Impact factor: 4.432

Review 9.  Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.

Authors:  Theresa A Lawrie; John T Green; Mark Beresford; Linda Wedlake; Sorrel Burden; Susan E Davidson; Simon Lal; Caroline C Henson; H Jervoise N Andreyev
Journal:  Cochrane Database Syst Rev       Date:  2018-01-23

Review 10.  Prophylactic Management of Radiation-Induced Nausea and Vomiting.

Authors:  Petra Feyer; Franziska Jahn; Karin Jordan
Journal:  Biomed Res Int       Date:  2015-09-03       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.